ROPINIROLE
NDC 43547-556, ropinirole, tablet, extended release, from Solco Healthcare US, LLC.
- Product NDC
- 43547-556
- Status
- Listed
- Labeler
- Solco Healthcare US, LLC
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204413
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43547-556 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ROPINIROLE6 mg/1
Pharmacologic classes
Dopamine Agonists [MoA]; Nonergot Dopamine Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43547-556-03 | 43547055603 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43547-556-03) |
| 43547-556-09 | 43547055609 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (43547-556-09) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/213dd2f4-4a71-456c-b3c7-b709c7bd7445NADAC price for package 43547055603
GET /v1/drugs/nadac/43547055603
Use it
Look up 43547-556 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43547-556 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43547-556. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.